Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

BD Completes Sales of Ophthalmic Systems Unit and Surgical Blades Product Platform

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Haemonetics Wins FDA Approval for Vascade...

Haemonetics has secured an expanded regulatory milestone in the...

FDA Clears Medtronic Stealth Axis for...

Medtronic’s Stealth Axis FDA clearance marks an expansion of...

Philips AI DeviceGuide Gets FDA Approval...

Regulatory clearance has been secured by Philips from the...

Hospital & Healthcare Management / Healthcare News :- BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the completion of the sale of its Ophthalmic Systems unit to RoundTable Healthcare Partners and the sale of its surgical blades product platform to one of RoundTable’s portfolio companies, Aspen Surgical Products, Inc.

On June 8, 2010, the Company announced that it had signed agreements to sell certain assets of its BD Medical segment, including the Ophthalmic Systems unit as well as the surgical blades, critical care and extended dwell catheter product platforms of the Medical Surgical Systems unit. BD expects to complete the sale of the critical care and extended dwell catheter product platforms to Roundtable Healthcare Partners during its fourth fiscal quarter (by September 30, 2010).

The Company expects to record a gain on these sale transactions in the fourth fiscal quarter 2010.  For the full fiscal year 2010, revenues and earnings per share associated with these asset groups were estimated at $200 million and $0.20, respectively.

MEDICAL FAIR ASIA 2026

Latest stories

Related stories

Haemonetics Wins FDA Approval for Vascade MVP XL System

Haemonetics has secured an expanded regulatory milestone in the...

FDA Clears Medtronic Stealth Axis for Cranial, ENT Uses

Medtronic’s Stealth Axis FDA clearance marks an expansion of...

Philips AI DeviceGuide Gets FDA Approval for Cardiac Use

Regulatory clearance has been secured by Philips from the...

GE HealthCare Drives Cardio-Oncology Care in EU COMPASS

GE HealthCare has taken on the role of lead...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »